Portage Biotech Stock Probability of Future Stock Price Finishing Over 36.4

PRTG Stock  USD 3.98  0.06  1.49%   
Portage Biotech's future price is the expected price of Portage Biotech instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Portage Biotech performance during a given time horizon utilizing its historical volatility. Check out Portage Biotech Backtesting, Portage Biotech Valuation, Portage Biotech Correlation, Portage Biotech Hype Analysis, Portage Biotech Volatility, Portage Biotech History as well as Portage Biotech Performance.
For more detail on how to invest in Portage Stock please use our How to Invest in Portage Biotech guide.
  
The current Price To Sales Ratio is estimated to decrease to 1,972. The current Price Earnings Ratio is estimated to decrease to -3.14. Please specify Portage Biotech's target price for which you would like Portage Biotech odds to be computed.

Portage Biotech Target Price Odds to finish over 36.4

The tendency of Portage Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 36.40  or more in 90 days
 3.98 90 days 36.40 
close to zero percent
Based on a normal probability distribution, the odds of Portage Biotech to move over $ 36.40  or more in 90 days from now is close to zero percent (This Portage Biotech probability density function shows the probability of Portage Stock to fall within a particular range of prices over 90 days) . Probability of Portage Biotech price to stay between its current price of $ 3.98  and $ 36.40  at the end of the 90-day period is about 81.05 .
Given the investment horizon of 90 days the stock has the beta coefficient of 5.64 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Portage Biotech will likely underperform. Additionally Portage Biotech has an alpha of 0.3668, implying that it can generate a 0.37 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Portage Biotech Price Density   
       Price  

Predictive Modules for Portage Biotech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Portage Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Portage Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.214.1821.19
Details
Intrinsic
Valuation
LowRealHigh
0.275.4522.46
Details
Naive
Forecast
LowNextHigh
0.14.9721.99
Details
1 Analysts
Consensus
LowTargetHigh
9.1010.0011.10
Details

Portage Biotech Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Portage Biotech is not an exception. The market had few large corrections towards the Portage Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Portage Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Portage Biotech within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.37
β
Beta against Dow Jones5.64
σ
Overall volatility
1.58
Ir
Information ratio 0.06

Portage Biotech Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Portage Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Portage Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Portage Biotech is way too risky over 90 days horizon
Portage Biotech appears to be risky and price may revert if volatility continues
Portage Biotech has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (75.34 M) with profit before overhead, payroll, taxes, and interest of 0.
Portage Biotech currently holds about 21.18 M in cash with (14.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.25.
Portage Biotech has a frail financial position based on the latest SEC disclosures
Roughly 30.0% of the company outstanding shares are owned by corporate insiders
Latest headline from gurufocus.com: Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024

Portage Biotech Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Portage Stock often depends not only on the future outlook of the current and potential Portage Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Portage Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding20.3 M
Cash And Short Term InvestmentsM

Portage Biotech Technical Analysis

Portage Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Portage Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Portage Biotech. In general, you should focus on analyzing Portage Stock price patterns and their correlations with different microeconomic environments and drivers.

Portage Biotech Predictive Forecast Models

Portage Biotech's time-series forecasting models is one of many Portage Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Portage Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Portage Biotech

Checking the ongoing alerts about Portage Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Portage Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Portage Biotech is way too risky over 90 days horizon
Portage Biotech appears to be risky and price may revert if volatility continues
Portage Biotech has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (75.34 M) with profit before overhead, payroll, taxes, and interest of 0.
Portage Biotech currently holds about 21.18 M in cash with (14.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.25.
Portage Biotech has a frail financial position based on the latest SEC disclosures
Roughly 30.0% of the company outstanding shares are owned by corporate insiders
Latest headline from gurufocus.com: Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024
When determining whether Portage Biotech is a strong investment it is important to analyze Portage Biotech's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Portage Biotech's future performance. For an informed investment choice regarding Portage Stock, refer to the following important reports:
Check out Portage Biotech Backtesting, Portage Biotech Valuation, Portage Biotech Correlation, Portage Biotech Hype Analysis, Portage Biotech Volatility, Portage Biotech History as well as Portage Biotech Performance.
For more detail on how to invest in Portage Stock please use our How to Invest in Portage Biotech guide.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Portage Biotech. If investors know Portage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Portage Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(70.40)
Return On Assets
(0.19)
Return On Equity
(1.91)
The market value of Portage Biotech is measured differently than its book value, which is the value of Portage that is recorded on the company's balance sheet. Investors also form their own opinion of Portage Biotech's value that differs from its market value or its book value, called intrinsic value, which is Portage Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Portage Biotech's market value can be influenced by many factors that don't directly affect Portage Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Portage Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Portage Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Portage Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.